Sectoral Asset Management Inc Albireo Pharma, Inc. Transaction History

Sectoral Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$16.92 - $28.96 $2.49 Million - $4.26 Million	-147,211 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.0 - $31.88 $1.92 Million - $3.05 Million	-95,767 Reduced 39.41%	147,211 $2.94 Million
Q1 2019 May 14, 2019	BUY	$22.22 - $32.21 $288,860 - $418,730	13,000 Added 5.65%	242,978 $7.83 Million
Q4 2018 Feb 12, 2019	BUY	$20.9 - $32.57 $844,360 - $1.32 Million	40,400 Added 21.31%	229,978 $5.64 Million
Q3 2018 Nov 14, 2018	BUY	$29.29 - $36.87 $491,339 - $618,494	16,775 Added 9.71%	189,578 $6.25 Million
Q1 2018 May 15, 2018	SELL	$26.78 - $39.35 $1.87 Million - $2.75 Million	-70,000 Reduced 28.83%	172,803 $5.63 Million
Q4 2017 Feb 13, 2018	BUY	$21.56 - $28.14 $1.83 Million - $2.39 Million	84,776 Added 53.65%	242,803 $6.22 Million
Q3 2017 Nov 14, 2017	BUY	$20.44 - $25.65 $3.23 Million - $4.05 Million	158,027	158,027 $3.31 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.